This gap emphasizes the critical need for integrated, multidisciplinary, and sustainable care strategies to support long-term behavioral change ( The presence of complex comorbidities in a subset of participantssuch as syndromic or hypothalamic obesity, neurodevelopmental disorders, and chronic systemic diseasesmay influence therapeutic responsiveness, potentially attenuating the magnitude of treatment effects
The alignment of these systemic clinical outcomes with the preservation of intracellular structures underscores a profound integration of endocrine control and organellar maintenance
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models
GLP-1 drugs are associated with a 35% higher risk of NAION, an eye condition that can cause sudden vision loss
This is because below the surface, your body adjusts to changing conditions
Mutants with a disrupted synthetic pathway contain lower levels of glutathione and are more susceptible to both pathogens and generalist insects 4,14,15,16,17
